South Korea · Delayed Price · Currency is KRW Hanmi Science Statistics
Total Valuation
Hanmi Science has a market cap or net worth of KRW 2.61 trillion. The enterprise value is 2.69 trillion.
| Market Cap | 2.61T |
| Enterprise Value | 2.69T |
Important Dates
The next estimated earnings date is Tuesday, April 28, 2026.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Hanmi Science has 67.71 million shares outstanding. The number of shares has increased by 0.12% in one year.
| Current Share Class | 67.71M |
| Shares Outstanding | 67.71M |
| Shares Change (YoY) | +0.12% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 36.23% |
| Owned by Institutions (%) | 15.03% |
| Float | 31.65M |
Valuation Ratios
The trailing PE ratio is 22.07.
| PE Ratio | 22.07 |
| Forward PE | n/a |
| PS Ratio | 1.92 |
| PB Ratio | 2.72 |
| P/TBV Ratio | 2.76 |
| P/FCF Ratio | 90.86 |
| P/OCF Ratio | 54.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.18, with an EV/FCF ratio of 93.77.
| EV / Earnings | 22.76 |
| EV / Sales | 1.99 |
| EV / EBITDA | 18.18 |
| EV / EBIT | 19.42 |
| EV / FCF | 93.77 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.22.
| Current Ratio | 0.80 |
| Quick Ratio | 0.48 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 3.23 |
| Debt / FCF | 7.47 |
| Interest Coverage | 5.39 |
Financial Efficiency
Return on equity (ROE) is 13.02% and return on invested capital (ROIC) is 4.80%.
| Return on Equity (ROE) | 13.02% |
| Return on Assets (ROA) | 2.51% |
| Return on Invested Capital (ROIC) | 4.80% |
| Return on Capital Employed (ROCE) | 5.66% |
| Weighted Average Cost of Capital (WACC) | 7.88% |
| Revenue Per Employee | 2.85B |
| Profits Per Employee | 248.68M |
| Employee Count | 476 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 9.04 |
Taxes
In the past 12 months, Hanmi Science has paid 15.29 billion in taxes.
| Income Tax | 15.29B |
| Effective Tax Rate | 11.50% |
Stock Price Statistics
The stock price has increased by +54.20% in the last 52 weeks. The beta is 0.71, so Hanmi Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +54.20% |
| 50-Day Moving Average | 40,399.00 |
| 200-Day Moving Average | 40,647.50 |
| Relative Strength Index (RSI) | 50.35 |
| Average Volume (20 Days) | 139,801 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hanmi Science had revenue of KRW 1.36 trillion and earned 118.37 billion in profits. Earnings per share was 1,747.00.
| Revenue | 1.36T |
| Gross Profit | 311.31B |
| Operating Income | 56.96B |
| Pretax Income | 133.00B |
| Net Income | 118.37B |
| EBITDA | 66.45B |
| EBIT | 56.96B |
| Earnings Per Share (EPS) | 1,747.00 |
Balance Sheet
The company has 128.17 billion in cash and 214.53 billion in debt, with a net cash position of -86.36 billion or -1,275.34 per share.
| Cash & Cash Equivalents | 128.17B |
| Total Debt | 214.53B |
| Net Cash | -86.36B |
| Net Cash Per Share | -1,275.34 |
| Equity (Book Value) | 959.19B |
| Book Value Per Share | 14,201.63 |
| Working Capital | -95.90B |
Cash Flow
In the last 12 months, operating cash flow was 47.66 billion and capital expenditures -18.93 billion, giving a free cash flow of 28.73 billion.
| Operating Cash Flow | 47.66B |
| Capital Expenditures | -18.93B |
| Depreciation & Amortization | 9.48B |
| Net Borrowing | -3.54B |
| Free Cash Flow | 28.73B |
| FCF Per Share | 424.29 |
Margins
Gross margin is 22.94%, with operating and profit margins of 4.20% and 8.72%.
| Gross Margin | 22.94% |
| Operating Margin | 4.20% |
| Pretax Margin | 9.80% |
| Profit Margin | 8.72% |
| EBITDA Margin | 4.90% |
| EBIT Margin | 4.20% |
| FCF Margin | 2.12% |
Dividends & Yields
This stock pays an annual dividend of 400.00, which amounts to a dividend yield of 1.05%.
| Dividend Per Share | 400.00 |
| Dividend Yield | 1.05% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 11.44% |
| Buyback Yield | -0.12% |
| Shareholder Yield | 0.94% |
| Earnings Yield | 4.53% |
| FCF Yield | 1.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 28, 2022. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 28, 2022 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Hanmi Science has an Altman Z-Score of 4.44 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.44 |
| Piotroski F-Score | 5 |